Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer--a comparison with CA15.3.

We report a comparative study of CA 15.3 and EMCA (epithelial mucin core antigen) in 77 consecutive women with newly diagnosed UICC assessable metastatic breast cancer, 59 patients received hormones and 18 chemotherapy. Assessments of response were made prior to commencing therapy and repeated 2 mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixon, A. R., Price, M. R., Hand, C. W., Sibley, P. E., Selby, C., Blamey, R. W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968729/
https://www.ncbi.nlm.nih.gov/pubmed/8217608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968729/
https://www.ncbi.nlm.nih.gov/pubmed/8217608

Ejemplares similares